[1] |
Kwon JM, Matern D, Kurtzberg J, et al. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease[J]. Orphanet J Rare Dis, 2018, 13(1): 30. DOI: 10.1186/s13023-018-0766-x.
|
[2] |
Allewelt H, Taskindoust M, Troy J, et al. Long-term functional outcomes after hematopoietic stem cell transplant for early infantile Krabbe disease[J]. Biol Blood Marrow Transplant, 2018, 24(11): 2233-2238. DOI: 10.1016/j.bbmt.2018.06.020.
|
[3] |
|
[4] |
郑纪鹏,盛慧英,黄永兰,等. 球形细胞脑白质营养不良的临床特点及基因突变分析[J]. 中国实用儿科杂志, 2014, 29(5): 367-372. DOI: 10.7504/ek2014040112.
|
[5] |
|
[6] |
|
[7] |
Bascou NA, Beltran-Quintero ML, Escolar ML. Pathogenic variants in GALC gene correlate with late onset krabbe disease and vision loss: case series and review of literature[J]. Front Neurol, 2020, 11: 563724. DOI: 10.3389/fneur.2020.563724.
|
[8] |
Corre CS, Matern D, Pellegrino JE, et al. Low psychosine in Krabbe disease with onset in late infancy: a case report[J]. Int J Neonatal Screen, 2021, 7(2): 28. DOI: 10.3390/ijns7020028.
|
[9] |
|
[10] |
Yang Y, Ren X, Xu Q, et al. Four novel GALC gene mutations in two Chinese patients with Krabbe disease[J]. Gene, 2013, 519(2): 381-384. DOI: 10.1016/j.gene.2013.02.010.
|
[11] |
Graziano AC, Cardile V. History, genetic, and recent advances on Krabbe disease[J]. Gene, 2015, 555(1): 2-13. DOI: 10.1016/j.gene.2014.09.046.
|
[12] |
Pannuzzo G, Graziano ACE, Avola R, et al. Screening for Krabbe disease: the first 2 years′ experience[J]. Acta Neurol Scand, 2019, 140(5): 359-365. DOI: 10.1111/ane.13153.
|
[13] |
Sakai N. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment[J]. Brain Dev, 2009, 31(7): 485-487. DOI: 10.1016/j.braindev.2009.03.001.
|
[14] |
Tappino B, Biancheri R, Mort M, et al. Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease[J]. Hum Mutat, 2010, 31(12): E1894-E1914. DOI: 10.1002/humu.21367.
|
[15] |
Orsini JJ, Escolar ML, Wasserstein MP, et al. Krabbe disease[M/OL]//Adam MP, Feldman J, Mirzaa GM, et al. GeneReviews®. Seattle (WA): University of Washington, Seattle, 1993-2024, (2018-10-11) [2024-04-02].
URL
|
[16] |
Korn-Lubetzki I, Dor-Wollman T, Soffer D, et al. Early peripheral nervous system manifestations of infantile Krabbe disease[J]. Pediatr Neurol, 2003, 28(2): 115-118. DOI: 10.1016/s0887-8994(02)00489-7.
|
[17] |
Duffner PK, Barczykowski A, Jalal K, et al. Early infantile Krabbe disease: results of the World-Wide Krabbe Registry[J]. Pediatr Neurol, 2011, 45(3): 141-148. DOI: 10.1016/j.pediatrneurol.2011.05.007.
|
[18] |
Zhuang S, Kong L, Li C, et al. GALC mutations in Chinese patients with late-onset Krabbe disease: a case report[J]. BMC Neurol, 2019, 19(1): 122. DOI: 10.1186/s12883-019-1345-z.
|
[19] |
Thompson-Stone R, Ream MA, Gelb M, et al. Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe disease[J]. Mol Genet Metab, 2021, 134(1-2): 53-59. DOI: 10.1016/j.ymgme.2021.03.016.
|
[20] |
Spacil Z, Tatipaka H, Barcenas M, et al. High-throughput assay of 9 lysosomal enzymes for newborn screening[J]. Clin Chem, 2013, 59(3): 502-511. DOI: 10.1373/clinchem.2012.189936.
|
[21] |
|
[22] |
Stenson PD, Mort M, Ball EV, et al. The Human Gene Mutation Database (HGMD?): optimizing its use in a clinical diagnostic or research setting[J]. Hum Genet, 2020, 139(10): 1197-1207. DOI: 10.1007/s00439-020-02199-3.
|
[23] |
Bongarzone ER, Escolar ML, Gray SJ, et al. Insights into the pathogenesis and treatment of Krabbe disease[J]. Pediatr Endocrinol Rev, 2016, 13(Suppl 1): 689-696.
|
[24] |
Komatsuzaki S, Zielonka M, Mountford WK, et al. Clinical characteristics of 248 patients with Krabbe disease: quantitative natural history modeling based on published cases[J]. Genet Med, 2019, 21(10): 2208-2215. DOI: 10.1038/s41436-019-0480-7.
|
[25] |
Ullah I, Waqas M, Ilyas M, et al. A novel variant of GALC in a familial case of Krabbe disease: insights from structural bioinformatics and molecular dynamics simulation[J]. Genes Dis, 2023, 10(6): 2263-2266. DOI: 10.1016/j.gendis.2023.01.018.
|
[26] |
Ghabash G, Wilkes J, Bonkowsky JL. National U.S. patient and transplant data for Krabbe disease[J]. Front Pediatr, 2021, 9: 764626. DOI: 10.3389/fped.2021.764626.
|
[27] |
Yoon IC, Bascou NA, Poe MD, et al. Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease[J]. Blood, 2021, 137(13): 1719-1730. DOI: 10.1182/blood.2020005477.
|
[28] |
van den Broek BTA, Page K, Paviglianiti A, et al. Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies[J]. Blood Adv, 2018, 2(1): 49-60. DOI: 10.1182/bloodadvances.2017010645.
|
[29] |
Bradbury AM, Bongarzone ER, Sands MS. Krabbe disease: new hope for an old disease[J]. Neurosci Lett, 2021, 752: 135841. DOI: 10.1016/j.neulet.2021.135841.
|
[30] |
Rutherford HA, Hamilton N. Animal models of leukodystrophy: a new perspective for the development of therapies[J]. FEBS J, 2019, 286(21): 4176-4191. DOI: 10.1111/febs.15060.
|
[31] |
Hordeaux J, Jeffrey BA, Jian J, et al. Efficacy and safety of a Krabbe disease gene therapy[J]. Hum Gene Ther, 2022, 33(9-10): 499-517. DOI: 10.1089/hum.2021.245.
|
[32] |
Wenger DA, Luzi P, Rafi MA. Advances in the diagnosis and treatment of Krabbe disease[J]. Int J Neonatal Screen, 2021, 7(3): 57. DOI: 10.3390/ijns7030057.
|